For further details see:
Connectyx buys rights to rabies immunotherapyFor further details see:
Connectyx buys rights to rabies immunotherapyMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Curative Biotechnology Inc Company Name:
CTYX Stock Symbol:
Market:
Boca Raton, FL, May 25, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company targeting novel treatments for rare diseases, filed its Q1 quarterly report for the period...
Biotechnology Company Issues Highlights and Subsequent Events Boca Raton, Fla, March 09, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on ...
Connectyx Announces Key Biotech Industry Veterans to Management Team Expertise in Clinical Development, Regulatory Affairs and Manufacturing Represented PR Newswire BOCA RATON, Fla. , Feb. 11, 2021 /PRNewswire/ -- Connectyx Technologies Holdings Group, I...